Hematopoietic stem cell transplantation for autoimmune diseases in developing countries: current status and future prospectives

Voltarelli, J C; Ouyang, J
August 2003
Bone Marrow Transplantation;Aug2003 Supplement 1, Vol. 32 Issue 1, pS69
Academic Journal
Summary:In this paper we present preliminary results of hematopoietic stem cell transplantation for autoimmune diseases in Brazil and China. Chinese experience transplanting lupus is significant and the Brazilian experience with several autoimmune diseases is growing. We discuss peculiar conditions in developing countries which could affect the results, and future prospectives for the organization of phase III randomized trials in those countries.Bone Marrow Transplantation (2003) 32, S69-S71. doi:10.1038/sj.bmt.1703947


Related Articles

  • Hematopoietic stem cell transplantation-associated thrombotic microangiopathy: defining a disorder. George, J. N. // Bone Marrow Transplantation;Jun2008, Vol. 41 Issue 11, p917 

    The author reflects on the importance of hematopoietic stem cell transplantation-associated thrombotic microangiopathy (TA-TMA). He remarks that TA-TMA's importance is documented not only by the experience of clinicians but also by extensive clinical investigation. He asserts that despite...

  • Reduced respiratory and skeletal muscle strength in survivors of sibling or unrelated donor hematopoietic stem cell transplantation. Kovalszki, A.; Schumaker, G. L.; Klein, A.; Terrin, N.; White, A. C. // Bone Marrow Transplantation;Jun2008, Vol. 41 Issue 11, p965 

    We performed a retrospective analysis of muscle strength testing obtained following sibling or unrelated donor hematopoietic stem cell transplant (HSCT) between 1 January 1999 and 31 December 2003 in a cohort of 44 subjects at Tufts-New England Medical Center. Maximal inspiratory pressure...

  • IL-4-producing CD8+ T cells may be an immunological hallmark of chronic GVHD. Nakamura, K.; Amakawa, R.; Takebayashi, M.; Son, Y.; Miyaji, M.; Tajima, K.; Nakai, K.; Ito, T.; Matsumoto, N.; Zen, K.; Kishimoto, Y.; Fukuhara, S. // Bone Marrow Transplantation;Oct2005, Vol. 36 Issue 7, p639 

    Summary:Chronic graft-versus-host disease (cGVHD) occurs in approximately 60–80% of those who survive over 100 days after allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, the pathophysiology of cGVHD is poorly understood. To gain more insight into the immunological...

  • A rare find - cells that improve bone marrow transplantation. Li, Xian Chang; Strom, Terry B. // Nature Medicine;Aug2000, Vol. 6 Issue 8, p866 

    Focuses on the improvement of bone marrow transplantation by facilitating cells. Promotion of hematopoietic stem cell engraftment by the facilitating cells; Role of facilitating cells in solid organ transplantation; Identification of facilitating cells in bone marrow by cell surface makers and ...

  • Enhancing bone marrow regeneration by SALL4 protein. Wenbin Liao; Aguila, Jerell R.; Yixin Yao; Jianchang Yang; Gary Zieve; Yongping Jiang; Avila, Cecilia; Lisa Senzel; Lai, Raymond; Dazhong Xu; Wei Dai; Yupo Ma // Journal of Hematology & Oncology;2013, Vol. 6 Issue 1, p1 

    Hematopoietic stem cells (HSCs) are widely used in transplantation therapy to treat a variety of blood diseases. The success of hematopoietic recovery is of high importance and closely related to the patient's morbidity and mortality after Hematopoietic stem cell transplantation (HSCT). We have...

  • Hematopoietic stem cell transplantation for multiple sclerosis: finding equipoise. Burt, R K; Kozak, T // Bone Marrow Transplantation;Aug2003 Supplement 1, Vol. 32 Issue 1, pS45 

    Summary:Hematopoietic stem cell transplantation of multiple sclerosis is rapidly expanding. Success for this approach requires an understanding of the pathophysiology of multiple sclerosis and design of trials that select patients with active inflammatory disease, low disability scores, and...

  • Mothers' Perceptions of Benefit Following Pediatric Stem Cell Transplantation: A Longitudinal Investigation of the Roles of Optimism, Medical Risk, and Sociodemographic Resources. Rini, Christine; Manne, Sharon; Duhamel, Katherine N.; Austin, Jane; Ostroff, Jamie; Boulad, Farid; Parsons, Susan K.; Martini, Richard; Williams, Sharon E.; Mee, Laura; Sexson, Sandra; Redd, William H. // Annals of Behavioral Medicine;2004, Vol. 28 Issue 2, p132 

    Background: This longitudinal study investigated the course and predictors of benefit finding among 144 mothers of children undergoing hematopoietic stem cell transplantation (HSCT), a severely stressful and life-threatening medical procedure. Purpose: Children's medical risk and mothers'...

  • Hematopoietic stem cell transplantation for severe rheumatoid arthritis. Moore, J J; Snowden, J; Pavletic, S; Barr, W; Burt, R // Bone Marrow Transplantation;Aug2003 Supplement 1, Vol. 32 Issue 1, pS53 

    Summary:The substantial morbidity and mortality associated with rheumatoid arthritis (RA), while not widely appreciated, provide adequate justification for consideration of high-dose immunoablative therapy followed by hematopoietic stem cell transplantation. While some patients with RA follow a...

  • Development of a phase III trial of hematopoietic stem cell transplantation for systemic lupus erythematosus. Burt, R K; Marmont, A; Arnold, R; Heipe, F; Firestein, G S; Carrier, E; Hahn, B; Barr, W; Oyama, Y; Snowden, J; Kalunian, K; Traynor, A // Bone Marrow Transplantation;Aug2003 Supplement 1, Vol. 32 Issue 1, pS49 

    Summary:At Northwestern University, a phase I/II trial of hematopoietic stem cell transplant (HSCT) for systemic lupus erythematosus (SLE) has shown promising results. A phase III HSCT trial is being developed to confirm efficacy of HSCT vs continuing the currently accepted standard of care,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics